Skip to content Skip to footer
Pegasys: Benefits, Reviews, Info, Side Effects!
Rx Details
Pegasys
Peginterferon alfa-2a, PegIFN, Pegylated interferon alfa-2a
Peginterferon alfa-2a
Prescription
Antiviral
Drugs
Prescription Only
chronic hepatitis C treatment, chronic hepatitis B treatment, reduces liver inflammation, slows liver damage, boosts immune response, improves liver function, decreases viral load
Abdominal Pain, Anxiety, Chills, Cough, Decreased Appetite, Depression, Diarrhea, Dizziness, Dry Skin, Fatigue, Fever, Flu-Like Symptoms, Hair Thinning, Headache, Injection Site Reactions, Insomnia, Irritability, Joint Pain, Low Blood Cell Counts, Muscle Aches, Nausea, Shortness Of Breath, Vomiting, Weight Loss
Pegasys is a brand name for peginterferon alfa-2a, a medication used primarily to treat hepatitis C and sometimes hepatitis B. The dosage of Pegasys can vary based on the condition being treated, the patient’s weight, and other factors. However, a common dosage for adults with chronic hepatitis C is 180 micrograms (mcg) injected subcutaneously once a week. It’s important to note that the exact dosage and treatment regimen should be determined by a healthcare provider based on individual patient needs. Always consult a healthcare professional for medical advice and before starting any new treatment.
Hepatitis b, hepatitis c
Pegasys has a well-established safety profile.
Interactions with ribavirin, telaprevir, boceprevir, didanosine, theophylline, methadone, zidovudine, stavudine, lamivudine
$1,000 – $5,000
$1,500 for a supply of 1 vial (135mcg/05ml) of solution for injection.

A Synopsis of

Pegasys

Pegasys is a medication that is commonly used in the treatment of chronic hepatitis B and C infections. It belongs to a class of drugs known as interferons, which are naturally occurring proteins in the body that help to fight off viruses and regulate the immune system.

Pegasys works by boosting the body’s immune response to the hepatitis virus, helping to reduce the viral load and slow down the progression of the disease. It is typically administered as an injection under the skin once a week, and the dosage may vary depending on the individual’s condition and response to treatment.

While Pegasys can be an effective treatment for hepatitis B and C, it is important to be aware of the potential side effects. Common side effects may include flu-like symptoms such as fever, chills, and muscle aches, as well as fatigue, headache, and injection site reactions. In some cases, more serious side effects such as depression, suicidal thoughts, and liver problems may occur, so it is important to closely monitor for any changes in mood or physical symptoms while taking this medication.

As with any medication, it is important to follow your healthcare provider’s instructions carefully and report any side effects or concerns promptly. Your healthcare provider will monitor your progress and may adjust your dosage or treatment plan as needed to ensure the best possible outcome.

Overall, Pegasys can be a valuable tool in the treatment of chronic hepatitis infections, but it is important to weigh the potential benefits against the risks and work closely with your healthcare provider to determine the best course of action for your individual situation.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN